documents: FDA-2002-N-0230-0004

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2002-N-0230-0004 FDA FDA-2002-N-0230 Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Adverse Drug Experience Reporting Notice Notice of Approval 2002-10-25T04:00:00Z 2002 10 2002-10-23T04:00:00Z   2025-04-23T14:00:44Z 02-26914 0 0 0900006480497970

Links from other tables